Reverse
Ten major dangers investors should be aware of before purchasing shares in the ₹1,842-crore Indigene IPO
On day one, the Indigene IPO was completely subscribed. Retail investors subscribed 1.50 times, employees 1.31 times, and non-institutional investors 4.13 times. The portion booked by qualified institutional purchasers was 5%. With 65 active clients globally, the company offers services for digitally led commercialization.
The Indegene IPO has received an amazing response in every category, and on its first day, it was completely booked. The retail investor part received 1.50 subscriptions, while the non-institutional investor category received 4.13 subscriptions. The staff quota was 1.31 times the subscription amount. According to BSE data, the Indegene IPO subscription status is 1.67 times every day.
The part reserved for qualified institutional purchasers is 5% booked. The Indegene IPO will close on Wednesday, May 8, having opened for subscriptions today, Monday, May 6.
The company provides digitally led commercialization services concerning drug development and clinical trials, regulatory filings, pharmacovigilance and complaints management, as well as product sales and marketing, to the life sciences industry, which comprises biopharmaceutical, emerging biotech, and medical device companies.
On December 31, 2023, there were sixty-five active clients of the company. The company offers them solutions and has operating centres in Europe, Asia, and North America. Thanks to their in-house developed proprietary platforms based on machine learning (ML) and artificial intelligence (AI), they are able to supply our solutions at scale globally.
An offer-for-sale (OFS) of 23,932,732 equity shares by the investor selling shareholder and a new issue of ₹760 crore make up the ₹1,841.76 crore Indigene IPO.
إرسال تعليق